Wednesday, August 06, 2003

cheap malaria drug approved

GlaxoSmithKline is the producer of the new drug.

According to GSK, a course of treatment with Lapdap will cost just 18 pence (29 US cents) for an adult and 9 pence for a child.

This is much cheaper than many existing drugs, some of which can cost as much as £33 per course.

.... The $5m development costs were shared between GSK, the WHO and the UK Department for International Development.